Ownership history in CITIGROUP INC · 95 quarters on record
This page tracks every 13F SEC filing in which CITIGROUP INC reported a position in ULTRAGENYX PHARMACEUTICAL IN (RARE). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | ADDED | 69,511 | +43,322 | +165.4% | 0.00% | $1.6M | $23.00 |
| 2025 Q3 | ADDED | 26,189 | +10,489 | +66.8% | 0.00% | $788K | $30.08 |
| 2025 Q3 | UNCHANGED | 15,700 | — | 0% | 0.00% | $472K | $30.08 |
| 2025 Q3 | REDUCED | 15,700 | -16,120 | -50.7% | 0.00% | $472K | $30.08 |
As of 2025 Q4 — sorted by position size